Home › Funds › Maple Rock Capital Partners Inc. › ELV

Maple Rock Capital Partners Inc. position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Maple Rock Capital Partners Inc. reported holding 191,500 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$74.1M, representing 1.45% of its reported portfolio and ranking #20 among its reported holdings. Maple Rock Capital Partners Inc. has disclosed ELV holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)191.50K sh
Reported value held$74.06M
Portfolio Weight1.45%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Maple Rock Capital Partners Inc.'s ELV position evolved

Maple Rock Capital Partners Inc. first disclosed a stake in ELV in Q1 2026 at 62,000 shares (US$18.2M). The position peaked in Q2 2026 at 191,500 shares, worth US$74.1M. Across 2 filings, Maple Rock Capital Partners Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 191,500 shares valued at US$74.1M — an increase of 129,500 shares quarter over quarter.. Notable position changes include a 209% increase in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 62.00K $18.15M New
Q2 2026 191.50K $74.06M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has Maple Rock Capital Partners Inc. held ELV?

Maple Rock Capital Partners Inc. has disclosed ELV holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Maple Rock Capital Partners Inc.'s current position in ELV?

As of Q2 2026, Maple Rock Capital Partners Inc. holds 191.50K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $74.06M, representing 1.45% of its reported portfolio and ranking #20.

Has Maple Rock Capital Partners Inc. been buying or selling ELV?

In the latest 13F filing (Q2 2026), Maple Rock Capital Partners Inc. increased its position in ELV. The position peaked in Q2 2026 at 191.50K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.